🎉 M&A multiples are live!
Check it out!

China Re Valuation Multiples

Discover revenue and EBITDA valuation multiples for China Re and similar public comparables like IRB(Re), Arab Insurance Group, and General Insurance.

China Re Overview

About China Re

China Reinsurance (Group) Corp is a Chinese company that is engaged in the reinsurance business. It provides various products and services including reinsurance, direct insurance, asset management, insurance brokerage, and insurance media service. The company offers a variety of reinsurance products for various property and casualty insurance, such as motor, property, agricultural, liability insurance, life, health, accident insurance, and asset management services. It operates through the following business segments: Property and casualty reinsurance, Life and health reinsurance, Primary property and casualty insurance, Asset Management, and Others.


Founded

1949

HQ

Hong Kong
Employees

50.0K+

Website

chinare.com.cn

Financials

LTM Revenue $17.5B

LTM EBITDA n/a

EV

$4.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

China Re Financials

China Re has a last 12-month revenue of $17.5B and a last 12-month EBITDA of n/a.

In the most recent fiscal year, China Re achieved revenue of $13.1B and an EBITDA of n/a.

China Re expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See China Re valuation multiples based on analyst estimates

China Re P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $21.6B $13.1B XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA n/a n/a XXX XXX XXX
EBITDA Margin NaN% NaN% XXX XXX XXX
Net Profit $818M $241M XXX XXX XXX
Net Margin 4% 2% XXX XXX XXX
Net Debt $381M $261M XXX XXX XXX

Financial data powered by Morningstar, Inc.

China Re Stock Performance

As of April 15, 2025, China Re's stock price is HKD 1 (or $0).

China Re has current market cap of HKD 36.1B (or $4.6B), and EV of HKD 37.1B (or $4.8B).

See China Re trading valuation data

China Re Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$4.8B $4.6B XXX XXX XXX XXX $0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

China Re Valuation Multiples

As of April 15, 2025, China Re has market cap of $4.6B and EV of $4.8B.

China Re's trades at 0.3x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate China Re's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for China Re and 10K+ public comps

China Re Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $4.8B XXX XXX XXX
EV/Revenue 0.4x XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E 6.4x XXX XXX XXX
P/E/Growth 0.2x XXX XXX XXX
EV/FCF 2.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get China Re Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

China Re Valuation Multiples

China Re's NTM/LTM revenue growth is 2%

China Re's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged n/a for the same period.

Over next 12 months, China Re's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate China Re's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for China Re and other 10K+ public comps

China Re Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -39% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth n/a XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 2% XXX XXX XXX XXX
G&A Expenses to Revenue 6% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

China Re Public Comps

See public comps and valuation multiples for Reinsurance and Insurance Carriers comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Arab Insurance Group XXX XXX XXX XXX XXX XXX
General Insurance XXX XXX XXX XXX XXX XXX
IRB(Re) XXX XXX XXX XXX XXX XXX
Qatar Insurance Group XXX XXX XXX XXX XXX XXX
Hannover Re XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

China Re M&A and Investment Activity

China Re acquired  XXX companies to date.

Last acquisition by China Re was  XXXXXXXX, XXXXX XXXXX XXXXXX . China Re acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by China Re

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About China Re

When was China Re founded? China Re was founded in 1949.
Where is China Re headquartered? China Re is headquartered in Hong Kong.
How many employees does China Re have? As of today, China Re has 50.0K+ employees.
Is China Re publicy listed? Yes, China Re is a public company listed on HKG.
What is the stock symbol of China Re? China Re trades under 01508 ticker.
When did China Re go public? China Re went public in 2015.
Who are competitors of China Re? Similar companies to China Re include e.g. Arab Insurance Group, General Insurance, IRB(Re), Qatar Insurance Group.
What is the current market cap of China Re? China Re's current market cap is $4.6B
What is the current revenue of China Re? China Re's last 12-month revenue is $17.5B.
What is the current EV/Revenue multiple of China Re? Current revenue multiple of China Re is 0.3x.
What is the current revenue growth of China Re? China Re revenue growth between 2023 and 2024 was -39%.
Is China Re profitable? Yes, China Re is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.